Grant: Canada First Research Excellence Fund
McGill University
$2,401,689.00
DNA to RNA: An Inclusive Canadian Approach to Genomic-based RNA Therapeutics (D2R)
EF 2024-25
Programme
Canada First Research Excellence FundCanada First Research Excellence Fund (lien de confiance élevée)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
SSHRC's Expenditures File
Tel que publié
Cle
9993508
File number
CFREF-2022-00045
Name nom
McGill University
Role rôle
Institution-Based Application
Amount montant
2401689.0
Fiscal year exercice financier
2024
Institution
McGill University
Établissement
Université McGill
Province id
QC
Province en
Quebec
Province fr
Québec
Competition year année du concours
2022
Title titre
DNA to RNA: An Inclusive Canadian Approach to Genomic-based RNA Therapeutics (D2R)
Keywords mots clés
RNA Therapeutics; Genomic Medicine Computational Biology Bioprocessing and Bioengineering Anti-Viral Vaccines Pre-Clinical and Clinical Research Indigenous Populations Social Determinants of Health Bioethics, Data Governance and Policy Infectious Diseases, Oncology and Rare Diseases
Program
Canada First Research Excellence Fund
Programme
Fonds d'excellence en recherche Apogée Canada
Sshrc discipline en
Care
Crsh discipline fr
Soins
Sshrc main discipline
Health sciences
Crsh discipline principale
Sciences de la santé
Sshrc area of research
Not Subject to Research Classification
Crsh domaine de recherche
Sans objet
Crdc field of research
Drug discovery, design and delivery; Personalized medicine
Ccrd domaine de recherche
Découverte, conception et administration de médicaments; Médecine personnalisée
